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Background and purpose   Spasticity and muscle contracture 
are two common manifestations of cerebral palsy (CP). A spastic 
muscle may inhibit growth in length of the muscle, but the impor-
tance of this relationship is not known. In 1994, a register and 
a healthcare program for children with CP in southern Sweden 
were initiated. The child’s muscle tone according to the Ashworth 
scale and the ankle range of motion (ROM) is measured annu-
ally during the entire growth period. We have used these data to 
analyze the relationship between spasticity and ROM of the gas-
trosoleus muscle. 
Patients and methods   All measurements in the total popula-
tion of children with CP aged 0–18 years during the period Janu-
ary 1995 through June 2008 were analyzed. The study was based 
on 2,796 examinations in 355 children. In the statistical analysis, 
the effect of muscle tone on ROM was estimated using a random 
effects model. 
Results   The range of dorsiflexion of the ankle joint decreased 
in the total material by mean 19 (95% CI: 14–24) degrees during 
the first 18 years of life. There was a statistically significant asso-
ciation between the ROM and the child’s level of spasticity during 
the year preceding the ROM measurement. 
Interpretation   Spasticity is related to the development of 
muscle contracture. In the treatment of children with CP, the 
spasticity, contracture, and strength of the gastrosoleus muscle 
must be considered together.

Spasticity has been defined as “a velocity-dependent increase 
in tonic stretch reflexes (muscle tone) with exaggerated tendon 
jerks, resulting from hyperexcitability of the stretch reflex, as 
one component of the upper motor neurone syndrome” (Lance 
1980). The spastic subtypes are the most common manifesta-
tions of cerebral palsy (CP) (Scholtes et al. 2006).
A spastic muscle will not allow stretch to the same degree 
as a muscle with normal tone. As a consequence, spasticity 
may inhibit growth in the length of the muscle, resulting in the 
development of muscle contracture—measured as a decreas-
ing range of joint motion (Rang et al. 1986). Other manifesta-
tions of CP, such as loss of selective muscle control, muscle 
weakness, or imbalance between agonists and antagonists 
may also result in the development of muscle contracture. 
In 1994, a CP register and a healthcare program, known as 
CPUP, were initiated for children with CP in southern Sweden 
(1.3 million inhabitants) (Hägglund et al. 2005a, b). The child’s 
local physiotherapist fills in a recording form 1–2 times a year. 
The recording form includes measurement of muscle tone of 
the gastrosoleus muscle according to the modified Ashworth 
scale (Bohannon and Smith 1987) and the range of motion of 
the ankle. These data have been used previously to follow the 
development of spasticity (Hägglund and Wagner 2008) and 
ROM (Nordmark et al. 2009) over time in children with CP. 
In the present study, we analyzed the relationship between 
spasticity and contracture of the gastrosoleus muscle in chil-
dren with CP.
Patients and methods
The CPUP register includes all children with CP who were 
born after January 1, 1990 and living in the counties of Skåne 
and Blekinge in southern Sweden (with a total population of 
about 1.3 million). The number of children with CP in the area 
corresponds to a prevalence of 2.4–2.6 per 1,000 living births 
(Nordmark et al. 2001, Westbom et al. 2007).
Our definition of cerebral palsy is that given by Mutch et 
al. (1992). The diagnosis is made by the child’s neuropedia-
trician. In the program, a continuing standardized follow-up Acta Orthopaedica 2011; 82 (6): 744–748  745
of gross and fine motor function, clinical findings, and treat-
ment is done. The local physiotherapists examine the child 
and fill in a recording form twice a year until the age of 6 
years, then once a year. There are 13 child habilitation units in 
the area, with about 80 physiotherapists involved in the CPUP 
program. The recording form includes the subtype of CP, the 
gross motor function, and muscle tone measured according 
to the modified Ashworth scale (Bohannon and Smith 1987). 
Ranges of motion (ROM) in all major joints are measured 
with a goniometer. The measurements are performed in stan-
dardized positions that are described in a manual accompany-
ing the recording form. 
The measurements of muscle tone of the gastrosoleus 
muscle and passive range of dorsiflexion of the ankle joint 
are done with the hip and knee extended. The CP subtype is 
classified according to the Surveillance of Cerebral Palsy in 
Europe network (SCPE) (2000). The gross motor function is 
classified according to the gross motor function classification 
system (GMFCS) (Palisano et al. 1997). In children measured 
before the publication of the GMFCS system in 1997, the 
child’s GMFCS level reported from 1997 was used. 
In the present study, we analyzed all measurements of 
muscle tone in the gastrosoleus muscle and all measurements 
of ROM in dorsiflexion of the ankle joint in children with 
CP from 0 to 18 years of age during the period January 1995 
through June 2008. Only children who had their first measure-
ment before 4 years of age were included, and only children 
with a definite diagnosis of CP. As diagnosis is not always 
possible before 4 years of age, we excluded children who were 
younger than 4 years in June 2008. For all children, informa-
tion from both legs was used in the analysis. 
Using these criteria, the study was based on 2,796 exami-
nations (5,592 legs) in 355 children. The distribution of CP 
subtypes, GMFCS levels, and measurements are presented in 
Tables 1 and 2. 48 children were treated with tendo Achillis 
or gastrocnemius lengthening. Only measurements up to the 
date of surgery were included in these children. 90 children 
were treated with botulinum toxin in the gastrosoleus muscle 
on 286 occasions. These children were most often examined 
more than 3 months after treatment, and they were included 
in the study.
Statistics
In the statistical analysis, due to the limited amount of data, the 
GMFCS levels were divided into two groups: I–III and IV–V. 
The Ashworth levels 1 and 1+ were gathered in one category, 
corresponding to the original Ashworth scale (Table 3). The 
effect of muscle tone on ROM was estimated using a random 
intercepts model. The model is a more flexible way to analyze 
unbalanced repeated measures data than the more common 
methods of analysis of variance (ANOVA), and is closely 
related to ordinary linear regression models (Fitzmaurice et 
al. 2004). Two random terms were included in the model in 
order to account for the covariance structure imposed on data 
by the inclusion of both legs in all children, one for correlation 
between data from the same individual and one for correlation 
between data for the same leg. In the statistical model, the 
effect of muscle tone on ROM was evaluated using the current 
level of muscle tone, measured simultaneously with ROM, 
and age effects were estimated using polynomial regression. 
The development of ROM with age, given a constant level 
of muscle tone, was predicted using the marginal means of 
the statistical model and plotted on a graph together with cor-
responding 95% confidence intervals (CIs). Plotted curves 
therefore correspond to the estimated population mean ROM 
given a specific age and level of muscle tone.
Table 1. Distribution of children in relation to CP subtypes based on the 
Surveillance of Cerebral Palsy in Europe (SCPE) and GMFCS level
CP subtype  GMFCS  Total
 I  II  III IV  V 
        
Spastic 
  unilateral  95  13 3 2 0  113
 bilateral  45 29 31 31 16  152
Dyskinetic  2 2 3  17  19  43
Ataxic  7 9 1 3 0  20
Mixed  7 3 6 4 7  27
Total  156 56 44 57 42  355
Table 2. Distribution of measurements in relation to CP subtypes based on 
the Surveillance of Cerebral Palsy in Europe (SCPE) and GMFCS level
CP subtype  GMFCS  Total
  I II III  IV V 
        
Spastic 
 unilateral  1,476  196  54  20  0  1,746
 bilateral  630 522 536 608 240  2,536
Dyskinetic  20  40  42 290 306  698
Ataxic  76 132  16  46  0  270
Mixed  80 36 56 70  100  342
Total  2,282 926 704  1,034 646  5,592
Table 3. The original Ashworth scale and the number of examinations at 
each level in the present study 
Score  Description of the muscle tone  Number of
   examinations
  
0  Normal tone, no increase in tone  1,586
1  Slight increase in tone producing a catch 
  when joint is moved in flexion or extension  2,151
2  More marked increase in tone through most 
  of range, but joint easily moved  1,033
3  Considerable increase in tone, passive 
  movement difficult   747 
4  Affected parts rigid in flexion or extension   75746  Acta Orthopaedica 2011; 82 (6): 744–748
The overall effect of muscle tone on ROM was evaluated by 
considering the average difference in ROM between children 
with normal muscle tone (Ashworth level 0) and children with 
a specific elevated level of muscle tone, over the entire follow-
up period from 0 to 18 years while correcting for age using the 
random intercepts model. In order to compare the effects of 
specific levels of muscle tone on ROM between subgroups, we 
used the fact that non-overlapping 95% confidence intervals 
indicate a statistically significant difference between estimates 
at the 5% level (Schenker and Gentleman 2001). STATA soft-
ware (StataCorp 2005) was used for the statistical analysis.
Ethics
The study was approved by the Medical Research Ethics 
Committee at Lund University (LU-443-99). 
Results
The observed average decrease in the range of dorsiflexion 
of the ankle joint in the total material was 19 degrees (95% 
CI: 14–24) during the period from 0–18 years of age. The 
observed annual decrease was faster up to approximately 5–6 
years of age (Figure 1).
The range of dorsiflexion was lower in children with higher 
levels of spasticity. The predicted development with age for 
these children is presented in Figure 2. Statistically significant 
differences in ROM were seen between all levels of spasticity, 
except between levels 1 and 2. 
The decreasing ROM with higher levels of spasticity was 
seen in all 4 CP subtypes and in both groups of GMFCS levels 
(Table 4). 
The difference in ROM between children with Ashworth 
level 1 and those with normal muscle tone (Ashworth level 0) 
varied between CP subtypes and GMFCS groups. The differ-
ences ranged from –0.3 (CI: –2.4 to 3.0) degrees in dyskinetic 
CP and GMFCS I–III to –5.8 (–7.9 to –3.6) degrees in ataxic 
CP and GMFCS I–III (Table 4). The corresponding differences 
Figure 1. Development of dorsiflexion of the ankle joint (mean, 95% 
CI) up to 18 years of age in the total sample of 355 children with CP. 
The analysis is based on 2,796 examinations of both legs in all 355 
children. 
Figure 2. Development of dorsiflexion of the ankle joint (mean, 95% CI) 
related to level of spasticity according to the Ashworth scale. 
Table 4. The predicted mean difference in ROM, between children with 
normal muscle tone and children with different levels of increased muscle 
tone, over the entire follow-up interval from 0 to 18 years, related to CP 
subtype and GMFCS level
 CP-subtype   GMFCS level  Mean difference   95% CI
Ashworth level
 
Spastic unilateral  I–III
  1     –4.5  (–5.3 to –3.8)
  2     –8.1  (–9.4 to –6.8)
  3     –15  (–17 to –13)
  4     –22  (–30 to –14)
Spastic bilateral  I–III
  1     –1.4  (–2.5 to –0.4)
  2     –3.6  (–4.9 to –2.4)
  3     –7.6  (–9.1 to –6.2)
  4     –17  (–21 to –13)
Spastic bilateral  IV–V
  1     –1.5  (–4.6 to 1.6)
  2     –1.2  (–4.0 to 2.2)
  3     –6.0  (–9.4 to –2.7)
  4     –14  (–20 to –9.0)
Dyskinetic I–III
  1     –0.3  (–2.4 to 3.0)
  2     –2.2  (–6.0 to 1.5)
  3     –7.3  (–11 to –3)
  4     –29  (–42 to –17)
Dyskinetic IV–V
  1     –4.8  (–7.7 to –1.8)
  2     –7.7  (–11 to – 4.5)
  3     –11  (–14 to –7.3)
  4     –21  (–28 to –14)
Ataxic a I–III
  1     –5.8  (–7.9 to –3.6)
  2     –7.1  (–10 to –4.2)
  3     –18  (–22 to –14)
 
a Only one child with ataxic CP and Ashworth level 4. Acta Orthopaedica 2011; 82 (6): 744–748  747
in ROM for children with Ashworth 4 ranged from –14 (–20 
to –9.0) degrees in spastic bilateral CP and GMFCS IV–V to 
–29 (–42 to –17) degrees in dyskinetic CP and GMFCS I–
III. Some of the differences in ROM related to CP subtype 
and GMFCS levels were statistically significant, indicating an 
influence of CP subtype and GMFCS level on the effect of 
spasticity on ROM. 
The numbers of examinations in the children with mixed 
subtype, and in children with spastic unilateral CP and ataxic 
CP at GMFCS levels IV–V was too small to permit these 
analyses. 
Discussion
We found that spasticity is related to the development of 
muscle contracture, measured as reduced ROM. We found 
a statistically significant difference in ROM across all sub-
groups between children with normal muscle tone (Ashworth 
level 0) and those with high muscle tone. The effect of each 
specific level of muscle tone varied across CP subtypes and 
GMFCS subgroups. Statistically significant differences were 
detected for both low and moderate spasticity levels. Differ-
ences were also seen for the effect of high spasticity levels, 
but they lacked statistical significance—possibly due to the 
relatively low number of measurements available for these 
children. Furthermore, the apparent increases in ROM at the 
end of the follow-up period (Figures 1 and 2) are additional 
statistical artifacts, due to an insufficient number of measure-
ments—which is apparent from the fact that the increases are 
not statistically significant. 
Spasticity is not the only condition responsible for the devel-
opment of muscle contracture. This is obvious from the fact 
that even children with normal muscle tone developed reduced 
ankle ROM. A restricted range of motion caused by reduced 
selective motor control, dysfunctional co-contraction, muscle 
weakness, or immobilization could probably also result in 
muscle contracture.
The classification of CP subtype according to SCPE is made 
from the most dominant syndrome. Many children with dyski-
netic CP also have spasticity (Himmelmann et al. 2007). The 
ataxic subtype includes children with ataxic diplegia, which 
explains why some children in this subgroup had increased 
muscle tone. 
We have previously shown that children with spastic CP 
have increasing muscle tone in the gastrocnemius muscle up 
to 4 years of age, followed by a decreasing tone up to 12 
years of age (Hägglund and Wagner 2008). Both the higher 
growth rate of the skeleton in the younger children and the 
higher degree of spasticity at younger ages could explain the 
faster decrease in ankle ROM before 5 years of age (Figure 
1). 
If a muscle is shortened, a given change in joint angle will 
stretch the muscle more than normal. This may potentiate the 
stretch reflex. In this way, a vicious circle could be set up with 
spasticity leading to muscle contracture, which would in turn 
increase spasticity (Nash et al. 1989).
The modified Ashworth scale is the most widely used instru-
ment for assessing spasticity. The modification from the origi-
nal scale is the addition of one level of measurement (1+) at 
the lower end of the scale. Some studies have shown problems 
with interobserver reliability with the Ashworth scale (Hass 
et al. 1996, Mutlu et al. 2008). The reliability is better with 
the original scale, as used in the present study (Nuyens et al. 
1994, Hass et al. 1996). Some studies have identified the Tar-
dieu scale to be a more sensitive instrument for measuring 
spasticity (Haugh et al. 2006), but it is to complicated to be 
used in a surveillance program or in a clinical follow-up of 
larger samples. In the present analysis, a low reliability—in 
the absence of systematic errors—would only be evident as 
underestimation of the effect of muscle tone on ROM. Thus, it 
will only affect our ability to correctly detect an actual change 
in ROM with muscle tone. 
 The validity of the Ashworth scale has been analysed in 
several studies (Scholtes et al. 2006). Leonard et al. (2001) 
compared the modified Ashworth scale with myometer mea-
surement of the biceps brachii and found a moderate to high 
correlation between the methods. Sköld et al. (1998) com-
pared EMG measurement of the quadriceps with estimation of 
spasticity according to the modified Ashworth scale in adults 
with spinal cord injury, and found a positive correlation. They 
concluded that the modified Ashworth scale accurately reflects 
movement-provoked spasticity. 
One limitation of our study was that only the current mea-
surement of muscle tone was used to estimate the effect of 
spasticity on ROM. The omission of data on past levels of 
muscle tone from the statistical model was mainly due to lack 
of balance of measurements of muscle tone and paucity of 
data due to the fact that younger and older children did not 
have complete follow-up data, as well as the fact that there 
were single measurements missing for some individuals. The 
inclusion of only the current measurement of muscle tone may 
have caused the past levels to act as confounders, inflating the 
estimate of the effect of current measurement of muscle tone 
on ROM. However, since we were interested in measuring the 
effect of all levels of muscle tone regardless of the time of 
measurement, this was not an issue for concern. 
Our study does not reflect the natural development of spas-
ticity and ROM, as some of the children had been treated to 
prevent the development of severe contracture. The CPUP 
program has reduced the number of children with severe con-
tracture and also the number of children who are operated for 
tendo Achillis lengthening (Hägglund et al 2005b). Children 
with shortening of the gastrocnemius muscle are often treated 
with physiotherapy and/or orthoses to reduce the shortening. 
If the children had not been treated, they would most probably 
have developed a larger decrease in ROM and the effect of 
spasticity would have been more pronounced. 748  Acta Orthopaedica 2011; 82 (6): 744–748
Of the 355 children, 90 had been treated with botulinum 
toxin A in the gastrosoleus muscle on an average of 3 occa-
sions. Most of the treatments were given more than 3 months 
before the examination. In relation to the 2,796 examinations 
in the study, these treatments should not have influenced the 
results. If a child is measured with a temporary lower degree 
of muscle tone caused by botulinum toxin, this would result in 
an underestimation of the effect of spasticity on ROM.
Both spasticity and contracture of the gastrosoleus muscle 
may interfere with ambulation, resulting in toe walking. How-
ever, spasticity and contracture may also compensate for 
weakness of the gastrosoleus muscle. The balance between 
muscle strength, muscle length, and muscle tone may result 
in toe walking in the younger child. The degree of spastic-
ity often becomes reduced between 4 and 12 years of age 
(Hägglund and Wagner 2008). The combination of reduced 
muscle tone and increased body weight with age might result 
in a change from toe walking to development of crouch, with 
increased dorsiflexion of the ankle joint during stance. We 
therefore recommend delay with decision on tendo Achillis 
lengthening until it is obvious that a short gastrosoleus muscle 
is not useful to compensate for the weakness of the muscle. 
The association between spasticity and development of 
contracture and their compensation for weakness is important 
in the treatment of children with CP. Reducing spasticity or 
increasing the range of dorsiflexion of the ankle joint is not 
always beneficial in the long term, and treatment with tempo-
rary methods, such as botulinum toxin, intrathecal baclofen 
pump, serial casting, or orthotics seems safer than permanent 
methods such as tendo Achillis lengthening or selective dorsal 
rhizotomy.
In summary, we found that spasticity of the gastrosoleus 
muscle is related to the development of muscle contracture, 
measured as reduced passive ankle ROM. Spasticity and con-
tracture of the gastrosoleus muscle may result in toe walking, 
and may also prevent development of crouch. In treatment 
planning, spasticity and the contracture and strength of the 
gastrosoleus muscle must be considered together in a long-
term perspective.
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